Sexual Health of Patients in Treatment for Lung Cancer: An Undercover Concern for Patients and Oncologists.

Sexual dysfunction (SD) prevalence in lung cancer (LC) patients is largely unknown. This study aims to assess the prevalence of SD among LC patients at our center. We conducted a cross-sectional survey of 69 patients using a questionnaire on sexual activity and satisfaction. Participants were recruited from 1 July 2023 to 30 September 2024 and had to be diagnosed with LC, age > 18 years, able to read, and with at least 1 month of treatment. A total of 61 patients completed the survey, predominantly male (67.2%) with stage IV LC (68.9%). Less than half (45.9%) reported recent sexual activity, while many expressed little to no interest (55.7%) and minimal satisfaction with their sex life (42.8%). The factors affecting sexual satisfaction included fatigue (37.7%) and feelings of anxiety/stress (24.6%). The reasons for decreased sexual activity included a lack of interest (36.4%), difficulties with erection (24.2%), and issues with partners (24.3%). A significant association was found between SD and the perceived impact of LC on sexual life, with higher dysfunction scores linked to more negative reports. SD is common among LC patients. Implementing assessment strategies and interventions may improve the sexual life of these patients.